BioWorld

July 12, 2004

View Archived Issues

Awaiting Approval For Surfaxin, Discovery Labs Accesses $75M

Although Discovery Laboratories Inc. has plenty of financial resources for near-term operations, the Doylestown, Pa.-based company secured a $75 million equity facility that it can access over the next three years. (BioWorld Today) Read More

TransTech Adding $30M To Extended Series E Financing

Read More

AMA Wants All Clinical Trial Results Entered In Database

Read More

Ligand's PPAR Drug Delayed By Field-Leveling' FDA Rule

Read More

Other News To Note

Read More

Appointments And Advancements

Read More